Long time no news on VISN!
08/18 10:18 SpectraSCIENCE Appoints Executive Vice President <SPSI.OB>
SpectraSCIENCE Appoints Executive Vice President
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 18, 1999--SpectraSCIENCE, Inc. (OTC:SPSI) announced today that Mr. Stephen M. Blinn has been appointed as its Executive Vice President. Mr. Blinn's duties will focus primarily on sales, marketing and new business development.
Mr. Blinn has extensive experience with the commercialization of medical devices that began in the Medical Products Division of 3M Company in the 1970's. During his career he has been involved with infection control systems, cardiac pacemakers, ambulatory infusion devices and, for the past 12 years, medical lasers.
From 1998 until July of 1999 Mr. Blinn served as President/CEO for SilverPlatter Education, Inc., an electronic medical publishing company. SilverPlatter was a turn-around situation that Mr. Blinn brought to profitability and successfully sold to HealthStream Corporation; a Nashville, Tennessee based company specializing in content aggregation of medical information for the Internet. In 1993 Mr. Blinn co-founded Sight Resource Corporation (NASDAQ: VISN) and served as its Chief Operating Officer until 1998. He continues to serve on its board of directors. While at Sight Resource he was instrumental in growing the company into the thirteenth largest primary eye care provider in the United States with over $50 million in annual revenue. From 1987 to 1993 Mr. Blinn served as Vice President of Sales and Marketing and then as Executive Vice President for Summit Technology (NASDAQ: BEAM), a worldwide leader in Laser Vision Correction utilizing excimer lasers. While at Summit he was directly responsible for opening 33 international markets and growing annual sales from $0 to $35 million prior to FDA approval.
Chet Sievert, President and CEO for SpectraSCIENCE, stated: "Steve's broad experience in the medical industry is extremely valuable to us as we move toward FDA approval for our Optical Biopsy(TM) System. His in-depth familiarity with medical device start-up companies and his knowledge regarding capital markets and new business development are particularly well suited to the immediate and future needs of the company. I am extremely pleased to welcome Steve on board and look forward to working with him during these exciting times for SpectraSCIENCE." Based in Minneapolis, SpectraSCIENCE, Inc. (www.spectrascience.com) develops innovative spectrophotometry systems capable of determining whether tissue is normal, potentially cancerous or cancerous. This news release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Additional risks that may affect the Company's future performance are detailed in Exhibit 99 to the Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 1999.
--30--dp/ms*
CONTACT: SpectraSCIENCE, Minneapolis
Marie Johnson
612-509-9999, extension 203. Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com (c) 1998 Business Wire |
